Signaling Pathways - MARK1 - HIV Integrases - IMPDH - ErbB
清除全部
- B1543 Mubritinib (TAK 165)中文名: 木利替尼Target: ErbBSummary: HER2/ErbB2有效抑制剂
- B1112 MerimepodibTarget: IMPDHSummary: IMPDH(肌苷单磷酸脱氢酶)的新型非竞争性抑制剂
- A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂
- A8319 Dacomitinib (PF299804, PF299)中文名: 达克替尼Target: ErbBSummary: HER抑制剂
- A8218 Lapatinib2 Citation中文名: 拉帕替尼Target: ErbBSummary: EGFR/HER2抑制剂
- A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂
- A4070 Elvitegravir (GS-9137)中文名: 埃替格韦Target: HIV IntegrasesSummary: HIV-1整合酶抑制剂
- A4069 BMS-707035Target: HIV IntegrasesSummary: HIV-1整合酶抑制剂
- A4092 CUDC-1011 CitationTarget: Histone Deacetylases (HDACs)|EGFR|ErbBSummary: 多靶点HDAC抑制剂